Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0000950123-10-085560
Filing Date
2010-09-13
Accepted
2010-09-13 11:35:58
Documents
1
Effectiveness Date
2010-09-13

Document Format Files

Seq Description Document Type Size
1 DFAN14A b82650dfan14a.htm DFAN14A 38308
  Complete submission text file 0000950123-10-085560.txt   40309
Mailing Address 4350 EXECUTIVE DRIVE,SUITE 325 SAN DIEGO CA 92121
Business Address 4350 EXECUTIVE DRIVE,SUITE 325 SAN DIEGO CA 92121 8584522323
CYPRESS BIOSCIENCE INC (Subject) CIK: 0000716054 (see all company filings)

EIN.: 222389839 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 000-12943 | Film No.: 101068569
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 20 PARK PLAZA, SUITE 905 BOSTON MA 02116
Business Address 20 PARK PLAZA, SUITE 905 BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001346824 (see all company filings)

EIN.: 830406777 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A